Stockreport

Citius Oncology Establishes International Access to LYMPHIR™ via Named Patient Programs in Southern Europe [Yahoo! Finance]

Citius Oncology, Inc.  (CTOR) 
PDF CRANFORD, N.J. Oct. 7, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on [Read more]